Available for Android and iOS devices. When reconstituted as directed with 4 mL of Sterile Water for Injection, each mL contains 50 mg of tedizolid phosphate. Palpitations were reported in 21/29 (72.4%) adult subjects exposed to Sivextro compared to 13/28 (46.4%) exposed to placebo in the tyramine challenge study.Serotonergic effects at doses of tedizolid phosphate up to 30-fold above the human equivalent dose did not differ from vehicle control in a mouse model that predicts serotonergic activity. You may report side effects to FDA at 1-800-FDA-1088.Tell your doctor about all your other medicines, especially:This list is not complete. Discard any unused portion.Serious Adverse Reactions and Adverse Reactions Leading to Discontinuation in AdultsNo increase in lesion surface area from baseline and oral temperature of ≤37.6°C, confirmed by a second temperature measurement within 24 hours at 48-72 hoursAt least a 20% decrease from baseline in lesion area at 48-72 hoursWhat should I tell my doctor before taking Sivextro?Tell your doctor about all of the medicines you take,Take Sivextro for 6 days, at the same time every dayIf you do not finish your medicine, Sivextro may not work.You may get sick again and the remaining bacteria may be harder to treat.If you have any side effect that bothers you or does not go away, tell your doctor.tedizolid phosphate injection, powder, lyophilized, for solutionWe comply with the HONcode standard for trustworthy health information - Version: 2.02.The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. In Trial 1, patients were treated with oral therapy, while in Trial 2, patients could receive oral therapy after a minimum of one day of intravenous therapy. 11.16 02.17 1Q18 Annual Review: policies combined for Medicaid and HIM lines of business. SIVEXTRO should be used only to treat infections that are proven or strongly suspected to be caused by susceptible strains of Gram-positive microorganisms. The percentage of responders to the primary endpoint was 85.2% and 82.6% in the Sivextro and linezolid arms, respectively. 11.16 02.17 1Q18 Annual Review: policies combined for Medicaid and HIM lines of business. Sivextro is an antibiotic that fights bacteria.Sivextro is used to treat skin infections in adults, including "MRSA" staph infections.To reduce the development of drug-resistant bacteria and maintain the effectiveness of Sivextro and other antibacterial drugs, this medicine should only be used to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. In addition, the film coating contains the following inactive ingredients: polyethylene glycol/macrogol, polyvinyl alcohol, talc, titanium dioxide, and yellow iron oxide.Sivextro for injection is a sterile, white to off-white sterile lyophilized powder supplied in a clear glass single-dose vial. Walker Winn, Pharm.D. for: Merck Sharp & Dohme Corp., a subsidiary ofSivextro tablets Manufactured by: Patheon Inc., Whitby, Ontario, L1N 5Z5 CanadaSivextro for injection Manufactured by: Patheon Italia S.p.A., 03013, Ferentino, FR ItalyFor patent information: www.merck.com/product/patent/home.htmlCopyright © 2017-2020 Merck Sharp & Dohme Corp., a subsidiary of This Patient Information has been approved by the U.S. Food and Drug Administration Revised: 6/2020The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Call your pharmacist for new medicine.Use this medicine for the full prescribed length of time, even if your symptoms quickly improve. Pharmacokinetic (PK) parameters of tedizolid following oral and intravenous administration of 200 mg once daily tedizolid phosphate are shown in Peak plasma tedizolid concentrations are achieved within approximately 3 hours following oral administration under fasting conditions or at the end of the 1 hour intravenous infusion of tedizolid phosphate.